Pharmaceutical GMP Training

January 17, 2018

Pharma biotech companies requiring entirely new or updated on-boarding or annual cGMP training programs turn to NSF International for an innovative approach and the very latest regulatory information and trends to ensure employees are gaining valuable cGMP knowledge which will help them in their work. Watch this brief video to learn more.

Spotlight

Cempra Pharmaceuticals

Cempra develops novel, well-differentiated antibiotics to meet critical unmet medical needs. Two lead products, both in clinical-stage development, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

OTHER VIDEOS

Pharmacy Management System Project in Python Source Code

video | May 21, 2022

Pharmacy Management System Project in Python Source Code What is Pharmacy Management System Project in Python...

Watch Now

AI accelerated drug discovery

video | May 20, 2022

AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of existing molecule, intelligent clinical design and coupled with in-house manufacturing....

Watch Now

Prescription Management System in SwilERP Pharmacy Software

video | May 27, 2022

Prescription Management is an essential task for the Pharmacist. The Prescription management feature of SwilERP Pharmacy Software enables the Pharmacists to create and maintain the medical records quickly and accurately evaluate the patient's health....

Watch Now

Accelerate Your Pharma 4.0 Journey with Our Manufacturing Execution Systems (MES) Solution

video | May 5, 2022

Today’s pharmaceutical manufacturers face increasing pressure to deliver high-quality medicines quickly, efficiently and economically while complying with regulatory requirements and meeting sustainability goals....

Watch Now

Spotlight

Cempra Pharmaceuticals

Cempra develops novel, well-differentiated antibiotics to meet critical unmet medical needs. Two lead products, both in clinical-stage development, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

Events